An umbrella term for conditions that link heart health and metabolism, things like type 2 diabetes, high blood pressure, abnormal cholesterol, and obesity, which tend to cluster together. GLP-1 medications are increasingly studied for cardiometabolic benefits beyond weight, including blood sugar and cardiovascular risk. Providers that frame their program as "cardiometabolic" usually emphasize lab monitoring and whole-picture care.
Related terms: Cardiovascular outcomes trial (CVOT) · Dyslipidemia · Insulin resistance · Type 2 diabetes